Tags

Type your tag names separated by a space and hit enter

[Anti-endomysium antibodies: a new marker for the diagnosis and treatment of celiac disease].
Pediatr Med Chir 1992 Jan-Feb; 14(1):33-6PM

Abstract

Coeliac disease is the most frequent cause of chronic diarrhea (1:1000 children) in Italy. It often has atypical symptoms, so a sensitive and specific test is needed that can both simplify the ESPGAM criteria and monitor compliance of patients to their gluten free diet. The AEmA (anti endomysium antibody), found by Chorzelsky in 1984, appears to be a very sensitive and specific screening test in the diagnosis of coeliac disease (CD). Sera from 150 children, mean age 4 years (range 6 months to 20 years) were tested for endomysium antibodies (IgA class) and anti gliadin antibodies (IgG class). From our preliminary study IgA-AEmA seem to be more specific for CD than IgG class anti-gliaadin antibodies.

Authors+Show Affiliations

Divisione Pediatrica, USL RM10, Ospedale S. Camillo de Lellis, Roma, Italia.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

English Abstract
Journal Article

Language

ita

PubMed ID

1579514

Citation

Calvani, M, et al. "[Anti-endomysium Antibodies: a New Marker for the Diagnosis and Treatment of Celiac Disease]." La Pediatria Medica E Chirurgica : Medical and Surgical Pediatrics, vol. 14, no. 1, 1992, pp. 33-6.
Calvani M, Parisi G, Miotti AM, et al. [Anti-endomysium antibodies: a new marker for the diagnosis and treatment of celiac disease]. Pediatr Med Chir. 1992;14(1):33-6.
Calvani, M., Parisi, G., Miotti, A. M., Alessandri, C., & Notarnicola, M. A. (1992). [Anti-endomysium antibodies: a new marker for the diagnosis and treatment of celiac disease]. La Pediatria Medica E Chirurgica : Medical and Surgical Pediatrics, 14(1), pp. 33-6.
Calvani M, et al. [Anti-endomysium Antibodies: a New Marker for the Diagnosis and Treatment of Celiac Disease]. Pediatr Med Chir. 1992;14(1):33-6. PubMed PMID: 1579514.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Anti-endomysium antibodies: a new marker for the diagnosis and treatment of celiac disease]. AU - Calvani,M,Jr AU - Parisi,G, AU - Miotti,A M, AU - Alessandri,C, AU - Notarnicola,M A, PY - 1992/1/11/pubmed PY - 2001/3/28/medline PY - 1992/1/11/entrez SP - 33 EP - 6 JF - La Pediatria medica e chirurgica : Medical and surgical pediatrics JO - Pediatr Med Chir VL - 14 IS - 1 N2 - Coeliac disease is the most frequent cause of chronic diarrhea (1:1000 children) in Italy. It often has atypical symptoms, so a sensitive and specific test is needed that can both simplify the ESPGAM criteria and monitor compliance of patients to their gluten free diet. The AEmA (anti endomysium antibody), found by Chorzelsky in 1984, appears to be a very sensitive and specific screening test in the diagnosis of coeliac disease (CD). Sera from 150 children, mean age 4 years (range 6 months to 20 years) were tested for endomysium antibodies (IgA class) and anti gliadin antibodies (IgG class). From our preliminary study IgA-AEmA seem to be more specific for CD than IgG class anti-gliaadin antibodies. SN - 0391-5387 UR - https://www.unboundmedicine.com/medline/citation/1579514/[Anti_endomysium_antibodies:_a_new_marker_for_the_diagnosis_and_treatment_of_celiac_disease]_ L2 - http://www.diseaseinfosearch.org/result/1186 DB - PRIME DP - Unbound Medicine ER -